Screening of Adolescent Mental Suffering

NCT01707576

Last updated date
Study Location
Department of paediatric emergencies, Ambroise Paré universitary hospital
Boulogne Billancourt, Ile de France, 92100, France
Contact
1-800-718-1021

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

By phone

Pfizer Clinical Trials Contact Center

1-800-718-1021

By email

Contact

[email protected]

Call Now

Eligibility Criteria
condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Depression, Adolescent, Self-report Questionnaire
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
13-17 years
Inclusion Criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Adolescents over the age of 13 to 17 years when passing emergency whatever the reason for consultation (surgical or medical, including attempted suicide or psychological problem)

Exclusion Criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details


- Young people not reading French.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

TRY A NEW SEARCH

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Depression, Adolescent, Self-report QuestionnaireScreening of Adolescent Mental Suffering
NCT01707576
  1. Boulogne Billancourt, Ile de France
ALL GENDERS
13 Years+
years
MULTIPLE SITES
Advanced Information
Descriptive Information
Brief Title  ICMJE Screening of Adolescent Mental Suffering
Official Title  ICMJE SCREENING OF ADOLESCENT MENTAL SUFFERING CONSULTANT TO EMERGENCIES, MANAGEMENT AND Later MONITORING
Brief Summary

The primary purpose is to estimate the prevalence of depression and subsyndromal states among adolescents 13 to 17 years consulting to hospital emergency rooms for any reason, for they are another way of tracking this suffering, as they host many troubled teens at once for health problems and accidents sometimes iterative, reflecting their risk behaviour.

Secondary purposes are to assess the feasibility and desirability of a post-emergency medical consultation for adolescents who scored high on a self-administered questionnaire, and to assess the impact of this approach by later monitoring.

Detailed Description

This is a multicenter longitudinal survey in three emergency centers in Ile-de-France, with 2 periods of daily collection and comprehensive three weeks spread over one year, followed by a remote evaluation.

The project is as follows:

Phase A :

- Evaluation of the prevalence: systematic execution of self-administered questionnaire by all adolescents consulting, night and day in each center.

Phase B :

  • For adolescents whose outcome questionnaire exceed 4, a post-emergency consultation will be proposed within 15 days.
  • Telephone survey, 12 months after the passage of emergency every teenager who completed self-administered questionnaire and presenting himself to the post-emergency consultation. This survey will aim to assess the psychological status of adolescents and the impact of any specific treatment.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Condition  ICMJE
  • Depression
  • Adolescent
  • Self-report Questionnaire
Intervention  ICMJE Behavioral: consultation 10 days later
new depression screening
Study Arms  ICMJE screening of adolescent mental suffering. Management
screening of adolescent mental suffering consultant to emergencies. Management and later monitoring
Intervention: Behavioral: consultation 10 days later
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: October 15, 2012)
346
Original Actual Enrollment  ICMJE Same as current
Actual Study Completion Date  ICMJE June 2012
Actual Primary Completion Date December 2011   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Adolescents over the age of 13 to 17 years when passing emergency whatever the reason for consultation (surgical or medical, including attempted suicide or psychological problem)

Exclusion Criteria:

  • Young people not reading French.
Sex/Gender  ICMJE
Sexes Eligible for Study:All
Ages  ICMJE 13 Years to 17 Years   (Child)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE France
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT01707576
Other Study ID Numbers  ICMJE P090103
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE Not Provided
Responsible Party Assistance Publique - Hôpitaux de Paris
Study Sponsor  ICMJE Assistance Publique - Hôpitaux de Paris
Collaborators  ICMJE
  • Pfizer
  • Fondation de France
Investigators  ICMJE
Principal Investigator:Chantal Stheneur, MDAmbroise Paré University Hospital
PRS Account Assistance Publique - Hôpitaux de Paris
Verification Date January 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP